Mr. Kay brings 55+ years of pharmaceutical industry knowledge to Juno Pharmaceuticals Canada’s board. From his early beginnings as a Registered Psychiatric Nurse, Jack progressed through the industry holding various positions culminating in a 35-year career with Apotex and finishing his assignment there as Chief Executive Officer. Jack has also served as Chairman of Helix Biopharma Corp., Chairman of Cangene Corp., and as a Director at Barr Pharmaceuticals Inc.  As a well-experienced industry expert, Jack is an invaluable asset to Juno.